Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 02/29/2024 | 11/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.60% | -12.78% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.53% | -12.81% | |||
| Operating Income | 3.53% | 12.81% | |||
| Income Before Tax | -13.52% | 94.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.52% | 94.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.52% | 94.27% | |||
| EBIT | 3.53% | 12.81% | |||
| EBITDA | 3.60% | 12.78% | |||
| EPS Basic | -1.30% | 89.94% | |||
| Normalized Basic EPS | -5.19% | 81.36% | |||
| EPS Diluted | -1.30% | 89.94% | |||
| Normalized Diluted EPS | -5.19% | 81.36% | |||
| Average Basic Shares Outstanding | 6.38% | 3.17% | |||
| Average Diluted Shares Outstanding | 6.38% | 3.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||